Effects of carbamazepine on acetylcholine release and metabolism

被引:24
作者
Mizuno, K [1 ]
Okada, M [1 ]
Murakami, T [1 ]
Kamata, A [1 ]
Zhu, G [1 ]
Kawata, Y [1 ]
Wada, K [1 ]
Kaneko, S [1 ]
机构
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan
关键词
acetylcholine; carbamazepine; epilepsy; hippocampus; microdialysis; striatum;
D O I
10.1016/S0920-1211(00)00129-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To clarify the mechanisms of action of carbamazepine (CBZ), we investigated the effects of CBZ on acetylcholine (ACh) release and metabolism in rat striatum and hippocampus. Acute administration of effective dose of CBZ (25 mg/kg) increased both striatal and hippocampal extracellular levels of ACh, whereas a supraeffective dose of CBZ (50 mg/kg) did not affect the levels and a toxic dose of CBZ (100 mg/kg) decreased the extracellular ACh levels in both brain legions. Both acute and chronic administrations of CBZ (25 and 50 mg/kg, mg/kg per day) increased intracellular ACh levels in striatum and hippocampus. The striatal intracellular ACh levels were decreased by both acute and chronic administrations of CBZ (100 mg/kg, mg/kg per day), whereas the hippocampal intracellular ACh levels were not affected. The effective CBZ concentration did not affect cholinesterase activity, whereas supraeffective CBZ concentration reduced it weakly. Effective dose of CBZ enhanced ACh release and synthesis; however, supraeffective doses of CBZ reduced ACh release and synthesis without enhancement of ACh degradation, indicating that CBZ has biphasic effects on ACh release and synthesis. Thus, the present findings, the slight stimulation of ACh function by effective dose of CBZ, are involved, at least partially, in the antiepileptic and mood stabilizing mechanisms of action of CBZ. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 47 条
[1]  
BERGMEYER HU, 1984, METHOD ENZYMAT AN, P52
[2]   Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy [J].
Bertrand, S ;
Weiland, S ;
Berkovic, SF ;
Steinlein, OK ;
Bertrand, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) :751-760
[3]  
BHATTACHARYA SK, 1991, INDIAN J EXP BIOL, V29, P237
[4]   A potassium channel mutation in neonatal human epilepsy [J].
Biervert, C ;
Schroeder, BC ;
Kubisch, C ;
Berkovic, SF ;
Propping, P ;
Jentsch, TJ ;
Steinlein, OK .
SCIENCE, 1998, 279 (5349) :403-406
[5]   M-CURRENTS - AN UPDATE [J].
BROWN, D .
TRENDS IN NEUROSCIENCES, 1988, 11 (07) :294-299
[6]   A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family [J].
Charlier, C ;
Singh, NA ;
Ryan, SG ;
Lewis, TB ;
Reus, BE ;
Leach, RJ ;
Leppert, M .
NATURE GENETICS, 1998, 18 (01) :53-55
[7]   PENTAMERIC STRUCTURE AND SUBUNIT STOICHIOMETRY OF A NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR [J].
COOPER, E ;
COUTURIER, S ;
BALLIVET, M .
NATURE, 1991, 350 (6315) :235-238
[8]   Ion channel genes and human neurological disease: Recent progress, prospects, and challenges [J].
Cooper, EC ;
Jan, LY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :4759-4766
[9]   INVOLVEMENT OF M1 MUSCARINIC RECEPTORS IN THE INITIATION OF CHOLINERGICALLY INDUCED EPILEPTIC SEIZURES IN THE RAT-BRAIN [J].
CRUICKSHANK, JW ;
BRUDZYNSKI, SM ;
MCLACHLAN, RS .
BRAIN RESEARCH, 1994, 643 (1-2) :125-129
[10]   UPREGULATION OF ADENOSINE-A1 RECEPTORS AND FORSKOLIN BINDING-SITES FOLLOWING CHRONIC TREATMENT WITH CAFFEINE OR CARBAMAZEPINE - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
DAVAL, JL ;
DECKERT, J ;
WEISS, SRB ;
POST, RM ;
MARANGOS, PJ .
EPILEPSIA, 1989, 30 (01) :26-33